WAT vs XERS · P/E 32, rev $3.17B vs rev $175.2M
Waters Corporation (WAT) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported WAT revenue for 2025-12-31 was $3.17B. Net income was $642.6M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
WAT currently screens at market cap $20.84B and trailing P/E 31.8. XERS currently screens at market cap $760.7M.
Not investment advice. Open the WAT and XERS stock pages for the full models.
Not investment advice.